Lonza in China
E-mail: -
Web: https://pharma.lonza.com/
Addresses:
-
Office 2 Lonza in China
No. 68, Huangge North Avenue Nansha District Guangzhou 511455, Guangdong Province
Phone: +86 20 3497 3888
Fax: -
-
Office 1 Lonza in China
No.1, Kangji Road Huangpu District Guangzhou 510555, Guangdong Province
Phone: +86 20 2889 3900
Fax: -
Other Lonza's locations around the world
Clinical Trials sponsored by Lonza
-
Lonza Ltd.AvslutadFriska volontärer | Återhämtning | EndotelfunktionTyskland
-
Biofortis, Merieux NutriSciencesLonza Inc.Avslutad
-
Biofortis, Merieux NutriSciencesLonza Inc.AvslutadTarmmikrobiotaFörenta staterna
-
KGK Science Inc.Lonza Inc.Avslutad
-
Applied Science & Performance InstituteLonza Ltd.AvslutadKroppssammansättning | Oxidativ stress | Muskelstyrka | Muskelskada | MotståndsträningFörenta staterna
-
Applied Science & Performance InstituteLonza Ltd.AvslutadOxidativ stress | Muskelömhet | Muskelstyrka | Muskelskada | MotståndsträningFörenta staterna
-
Applied Science & Performance InstituteLonza Ltd.AvslutadOxidativ stress | Muskelstyrka | Muskelskada | Motståndsträning | ImmunsuppressionFörenta staterna
-
Applied Science & Performance InstituteLonza Ltd.AvslutadKroppssammansättning | Oxidativ stress | Muskelstyrka | Muskelskada | MotståndsträningFörenta staterna
-
Fred Hutchinson Cancer CenterLonza Walkersville, Inc.RekryteringSteg IV Bukspottkörtelcancer AJCC v8 | Metastaserande pankreatisk duktal adenokarcinomFörenta staterna
About Lonza
Innovation lies at the heart of our mission to enable our customers to meet challenging deadlines and address their patients’ needs. Research & Development (R&D) plays a central role in how we approach innovation. It provides us with a long-term vision and ensures we make appropriate investments into extending our technology and capabilities to develop the tools we need for our future success.
Our scientific mindset, 360º view of industry trends and experience in transforming discovery into manufacturing applications, have been applied on multiple fronts throughout 2020. Our 14 R&D sites worldwide are an integral part of our global network and support innovation across the business.
Innovation does not happen in isolation. It is underpinned by strong synergies across all our R&D focus areas. Our R&D group is active in viral vectors, cell line construction, cell culture media, cell and gene therapies, capsule design and manufacturing, other oral dosage forms, chemical active pharmaceutical ingredients (APIs) and parenteral formulation and delivery. It is also involved in bio manufacturing and digital technology. Our key areas of interest are summarized here.